| pubmed-article:7674321 | pubmed:abstractText | Cancer cells of microscopic metastases can be envisaged as ideal constituents for the development of a genetically modified, autologous tumor cell vaccine. However, their extremely low number has thus far blocked this approach. | lld:pubmed |
